AbbVie Takes Takeda To Chancery Over Lupron Shortfall
AbbVie Endocrine Inc. sued Japan's Takeda Pharmaceutical Co. Ltd. in Delaware's Chancery Court late Friday, accusing it of breaching a license and supply agreement covering the prostate cancer and endometriosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article